KR
KROGER CO
$63.57
+2.14%
$38.9B
No data for this timeframe.
Vol
Market Cap$38.9B
Cap SizeLarge Cap
Analyst ConsensusBuy (58%)
Inst. Holders10 funds
Inst. Value$10.8B
Inst. Activity2 buys / 1 sells
SEC Reports7
Congressional3 trades
Recent Activity
Jun 6, 2026
SEC
In the Generic Pharmaceuticals MDL, Judge Rufe partially granted and partially denied Epic Pharma's motions to dismiss a
COURT-RULING — Impact 4/10
Jun 3, 2026
SEC
In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court denied Epic Pharma's motions to dismiss claims a
COURT-RULING — Impact 4/10
Jun 1, 2026
Insider
Aufreiter Nora A sold 61.021 shares
Director @ $61.52 ($3.8K)
Jun 1, 2026
Insider
SARGENT RONALD sold 388.213 shares
Chairman of the Board @ $61.52 ($23.9K)
Jun 1, 2026
Insider
Gates Anne sold 137.555 shares
Director @ $61.52 ($8.5K)
May 27, 2026
SEC
Kroger EVP and Associate Experience Officer Timothy A. Massa notified the company of his intention to retire in fall 202
8-K — Impact 2/10
Inst.
NORGES BANK — NEW
7,531,387 shares ($470.6M)
Inst.
TWO SIGMA INVESTMENTS, LP — DOUBLED
1,221,116 shares ($76.3M)
Price Targets
$75.45
+18.7% upside
Buy
Current $63.57
Low $61.00
Median $75.50
High $86.00
22 analysts
$61.00
$86.00
Analyst Ratings
9Strong Buy
10Buy
14Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Mar 9, 2026 | Evercore ISI Group | MAINTAIN | Outperform → Outperform |
| Mar 9, 2026 | Citigroup | MAINTAIN | Neutral → Neutral |
| Mar 6, 2026 | Roth Capital | REITERATE | Buy → Buy |
| Mar 6, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
| Mar 5, 2026 | Telsey Advisory Group | MAINTAIN | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next Q | $1.13 | $1.09 — $1.20 | 9% YoY | 18 |
| Current FY | $5.24 | $5.15 — $5.34 | 8% YoY | 24 |
| Next FY | $5.62 | $5.37 — $5.94 | 7% YoY | 21 |
| Current Q | $1.58 | $1.55 — $1.66 | 6% YoY | 18 |
Latest Reports
NEUTRAL
COURT-RULING
4/10
In the Generic Pharmaceuticals MDL, Judge Rufe partially granted and partially denied Epic Pharma's motions to dismiss a
Jun 6, 2026
NEUTRAL
COURT-RULING
4/10
In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court denied Epic Pharma's motions to dismiss claims a
Jun 3, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $4.8B | — |
| BERKSHIRE HATHAWAY INC | $3.1B | NEW |
| FMR LLC | $947.6M | ADD |
| MORGAN STANLEY | $632.9M | — |
| NORGES BANK | $470.6M | NEW |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Aufreiter Nora | A | $3.8K |
| Jun 1, 2026 | SARGENT RONALD | A | $23.9K |
| Jun 1, 2026 | Gates Anne | A | $8.5K |
| Jun 1, 2026 | Sutton Mark | A | $2.6K |
| Jun 1, 2026 | Chao Elaine | A | $5.4K |
Congressional Trades
2 members: 1 buys, 2 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| David Taylor | R | SELL | $1,001 - $15,000 |
| John Boozman | R | BUY | $1,001 - $15,000 |
| David Taylor | R | SELL | $1,001 - $15,000 |
10 institutional holders with $10.8B total value (172,323,122 shares) as of 2025-Q4. Top holders: VANGUARD, BERKSHIRE, FMR. Net buying activity: 2 institutions added/increased vs 1 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 77,169,425 | $4.8B | 44.8% | — |
| 2 | BERKSHIRE HATHAWAY INC | 50,000,000 | $3.1B | 29.0% | NEW |
| 3 | FMR LLC | 15,166,478 | $947.6M | 8.8% | ADD +36.7% |
| 4 | MORGAN STANLEY | 10,130,194 | $632.9M | 5.9% | — |
| 5 | NORGES BANK | 7,531,387 | $470.6M | 4.4% | NEW |
| 6 | BANK OF AMERICA CORP /DE/ | 5,164,860 | $322.7M | 3.0% | — |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4,768,229 | $297.9M | 2.8% | NEW |
| 8 | TWO SIGMA INVESTMENTS, LP | 1,221,116 | $76.3M | 0.7% | DOUBLED +3131.4% |
| 9 | WELLS FARGO & COMPANY/MN | 1,143,733 | $71.5M | 0.7% | TRIM -73.5% |
| 10 | RENAISSANCE TECHNOLOGIES LLC | 27,700 | $1.7M | 0.0% | NEAR_EXIT -94.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 7,531,387 | — | $470.6M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | DOUBLED | 37,789 | 1,221,116 | +3131.4% | $76.3M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 527,916 | 27,700 | -94.8% | $1.7M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 3,707,901 | 981,225 | -73.5% | $66.1M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 1,835,251 | 527,916 | -71.2% | $35.6M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 1,293,482 | 37,789 | -97.1% | $2.5M | 2025-Q3 |
| NORGES BANK | EXIT | 7,225,246 | 0 | -100.0% | $0.00 | 2025-Q3 |
| SOUND SHORE MANAGEMENT INC /CT/ | EXIT | 888,544 | 0 | -100.0% | $0.00 | 2025-Q3 |
| BERKSHIRE HATHAWAY INC | NEW | — | 50,000,000 | — | $3.6B | 2025-Q2 |
| FMR LLC | ADD | 9,050,987 | 12,371,220 | +36.7% | $887.4M | 2025-Q2 |
| NORGES BANK | NEW | — | 7,225,246 | — | $518.3M | 2025-Q2 |
| SOUND SHORE MANAGEMENT INC /CT/ | TRIM | 1,197,118 | 888,544 | -25.8% | $63.7M | 2025-Q2 |
| Fund 1 Investments, LLC | EXIT | 1,000 | 0 | -100.0% | $0.00 | 2025-Q2 |
| FMR LLC | ADD | 7,054,824 | 9,050,987 | +28.3% | $612.7M | 2025-Q1 |
| WELLS FARGO & COMPANY/MN | TRIM | 8,385,830 | 4,008,935 | -52.2% | $271.4M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | ADD | 753,541 | 1,301,858 | +72.8% | $88.1M | 2025-Q1 |
| Fund 1 Investments, LLC | TRIM | 3,438 | 1,000 | -70.9% | $67.7K | 2025-Q1 |
| NORGES BANK | EXIT | 9,785,603 | 0 | -100.0% | $0.00 | 2025-Q1 |
| BERKSHIRE HATHAWAY INC | EXIT | 50,000,000 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | ADD | 6,681,113 | 9,162,005 | +37.1% | $560.3M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 1,401,486 | 8,385,830 | +498.4% | $512.8M | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 4,051,770 | 2,364,851 | -41.6% | $144.6M | 2024-Q4 |
| Fund 1 Investments, LLC | NEW | — | 3,438 | — | $210.2K | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 4,890,887 | — | $280.2M | 2024-Q3 |
18 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Aufreiter Nora A | Director | A | 61.021 | $61.52 | $3.8K |
| Jun 1, 2026 | SARGENT RONALD | Chairman of the Board | A | 388.213 | $61.52 | $23.9K |
| Jun 1, 2026 | Gates Anne | Director | A | 137.555 | $61.52 | $8.5K |
| Jun 1, 2026 | Sutton Mark S | Director | A | 42.002 | $61.52 | $2.6K |
| Jun 1, 2026 | Chao Elaine L. | Director | A | 88.021 | $61.52 | $5.4K |
| Mar 31, 2026 | Chao Elaine L. | Director | A | 387.969 | $67.66 | $26.3K |
| Mar 13, 2026 | Arreaga Gabriel | Executive Vice President | F | 3,163 | $75.60 | $239.1K |
| Mar 13, 2026 | Adcock Mary Ellen | Executive Vice President | F | 5,182 | $75.60 | $391.8K |
| Mar 13, 2026 | Massa Timothy A | Executive Vice President | F | 5,676 | $75.60 | $429.1K |
| Mar 13, 2026 | Nichols Brian W | Group VP & Controller | F | 755 | $75.60 | $57.1K |
| Mar 13, 2026 | SARGENT RONALD | Chairman of the Board | F | 26,567 | $75.60 | $2.0M |
| Mar 13, 2026 | Kennerley David John Christopher | Executive Vice President & CFO | F | 7,743 | $75.60 | $585.4K |
| Mar 13, 2026 | Smith Victor Remon | Senior Vice President | F | 574 | $75.60 | $43.4K |
| Mar 13, 2026 | Shaffer Megan N. | Group Vice President | F | 1,112 | $75.60 | $84.1K |
| Mar 13, 2026 | Kelley Joseph Michael | Senior Vice President | F | 782 | $75.60 | $59.1K |
| Mar 13, 2026 | Jabbar Valerie L. | Senior Vice President | F | 2,400 | $75.60 | $181.4K |
| Mar 13, 2026 | FIKE CARIN L | Vice President and Treasurer | F | 186 | $75.60 | $14.1K |
| Mar 13, 2026 | COSSET YAEL | Executive Vice President | F | 6,694 | $75.60 | $506.1K |
| Mar 12, 2026 | Arreaga Gabriel | Executive Vice President | A | 6,504 | $0.00 | $0.00 |
| Mar 12, 2026 | Arreaga Gabriel | Executive Vice President | F | 1,906 | $74.96 | $142.9K |
| Mar 12, 2026 | Adcock Mary Ellen | Executive Vice President | A | 43,459 | $0.00 | $0.00 |
| Mar 12, 2026 | COSSET YAEL | Executive Vice President | A | 50,702 | $0.00 | $0.00 |
| Mar 12, 2026 | Adcock Mary Ellen | Executive Vice President | A | 10,270 | $0.00 | $0.00 |
| Mar 12, 2026 | Adcock Mary Ellen | Executive Vice President | F | 4,509 | $74.96 | $338.0K |
| Mar 12, 2026 | COSSET YAEL | Executive Vice President | A | 14,549 | $0.00 | $0.00 |
| Mar 12, 2026 | Kelley Joseph Michael | Senior Vice President | A | 14,487 | $0.00 | $0.00 |
| Mar 12, 2026 | Shaffer Megan N. | Group Vice President | A | 6,791 | $0.00 | $0.00 |
| Mar 12, 2026 | Jabbar Valerie L. | Senior Vice President | F | 2,255 | $74.96 | $169.0K |
| Mar 12, 2026 | Massa Timothy A | Executive Vice President | A | 10,270 | $0.00 | $0.00 |
| Mar 12, 2026 | Massa Timothy A | Executive Vice President | F | 4,509 | $74.96 | $338.0K |
| Mar 12, 2026 | Nichols Brian W | Group VP & Controller | F | 461 | $74.96 | $34.6K |
| Mar 12, 2026 | Foran Gregory S | Chief Executive Officer | A | 108,647 | $0.00 | $0.00 |
| Mar 12, 2026 | Massa Timothy A | Executive Vice President | A | 45,270 | $0.00 | $0.00 |
| Mar 12, 2026 | Nichols Brian W | Group VP & Controller | A | 9,281 | $0.00 | $0.00 |
| Mar 12, 2026 | Shaffer Megan N. | Group Vice President | A | 1,157 | $0.00 | $0.00 |
| Mar 12, 2026 | Vincent George H. | Executive Vice President | F | 254 | $74.96 | $19.0K |
| Mar 12, 2026 | Kennerley David John Christopher | Executive Vice President & CFO | A | 3,177 | $0.00 | $0.00 |
| Mar 12, 2026 | Kennerley David John Christopher | Executive Vice President & CFO | F | 1,429 | $74.96 | $107.1K |
| Mar 12, 2026 | Foran Gregory S | Chief Executive Officer | A | 48,026 | $0.00 | $0.00 |
| Mar 12, 2026 | Jabbar Valerie L. | Senior Vice President | A | 18,108 | $0.00 | $0.00 |
| Mar 12, 2026 | FIKE CARIN L | Vice President and Treasurer | F | 340 | $74.96 | $25.5K |
| Mar 12, 2026 | Jabbar Valerie L. | Senior Vice President | A | 5,135 | $0.00 | $0.00 |
| Mar 12, 2026 | Smith Victor Remon | Senior Vice President | A | 2,451 | $0.00 | $0.00 |
| Mar 12, 2026 | Smith Victor Remon | Senior Vice President | F | 725 | $74.96 | $54.3K |
| Mar 12, 2026 | Smith Victor Remon | Senior Vice President | A | 19,014 | $0.00 | $0.00 |
| Mar 12, 2026 | Vincent George H. | Executive Vice President | A | 850 | $0.00 | $0.00 |
| Mar 12, 2026 | Vincent George H. | Executive Vice President | A | 17,203 | $0.00 | $0.00 |
| Mar 12, 2026 | Shaffer Megan N. | Group Vice President | F | 529 | $74.96 | $39.7K |
| Mar 12, 2026 | Kelley Joseph Michael | Senior Vice President | A | 2,941 | $0.00 | $0.00 |
| Mar 12, 2026 | Kelley Joseph Michael | Senior Vice President | F | 1,292 | $74.96 | $96.8K |
7 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 1 mixed, 4 neutral. Avg impact: 4.3/10.
NEUTRAL
COURT-RULING
4/10
In the Generic Pharmaceuticals MDL, Judge Rufe partially granted and partially denied Epic Pharma's
Jun 6, 2026
NEUTRAL
COURT-RULING
4/10
In the Generic Pharmaceuticals MDL 2724 antitrust litigation, the court denied Epic Pharma's motions
Jun 3, 2026
NEUTRAL
8-K
2/10
Kroger EVP and Associate Experience Officer Timothy A. Massa notified the company of his intention t
May 27, 2026
BEARISH
COURT-RULING
5/10
The Ninth Circuit affirmed class certification in a consumer class action against Kroger (Fred Meyer
May 19, 2026
MIXED
COURT-RULING
4/10
The California Court of Appeal reversed a trial court judgment that had dismissed a Proposition 65 l
Apr 29, 2026
NEUTRAL
S-3ASR
3/10
The Kroger Co. filed a shelf registration (S-3ASR) to potentially issue up to $5 billion in debt, pr
Apr 21, 2026
BULLISH
8-K
8/10
Kroger reported strong fourth quarter and full-year 2025 results, with identical sales (excluding fu
Mar 5, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (58% buy). Based on 33 analysts: 9 strong buy, 10 buy, 14 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$75.45 mean target
+18.7% upside
Buy (2.08)
$61.00 Low
$86.00 High
| Metric | Value |
|---|---|
| Current Price | $63.57 |
| Target Low | $61.00 |
| Target Mean | $75.45 |
| Target Median | $75.50 |
| Target High | $86.00 |
| # Analysts | 22 |
| Recommendation | Buy (2.08) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next Q 2026-07-31 |
$1.13 | $1.09 | $1.20 | 9.0% | -0.1% | 0↑ 1↓ | $34.3B | 0.9% | 18 |
| Current FY 2027-01-31 |
$5.24 | $5.15 | $5.34 | 8.0% | -0.0% | 3↑ 16↓ | $149.7B | 1.4% | 24 |
| Next FY 2028-01-31 |
$5.62 | $5.37 | $5.94 | 7.3% | +0.0% | 2↑ 1↓ | $153.0B | 2.2% | 21 |
| Current Q 2026-04-30 |
$1.58 | $1.55 | $1.66 | 6.3% | -0.1% | 1↑ 13↓ | $45.4B | 0.6% | 18 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.584 | |
| 7d ago | $1.584 | -0.001 |
| 30d ago | $1.585 | -0.001 |
| 60d ago | $1.585 | -0.002 |
| 90d ago | $1.685 | -0.101 |
13 analyst firms have rated this stock: 1 upgrades, 2 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Mar 9, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 9, 2026 | Citigroup | MAINTAIN | Neutral | Neutral |
| Mar 6, 2026 | Roth Capital | REITERATE | Buy | Buy |
| Mar 6, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Mar 5, 2026 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Feb 25, 2026 | Wells Fargo | DOWNGRADE | Overweight | Equal-Weight |
| Feb 10, 2026 | Guggenheim | REITERATE | Buy | Buy |
| Feb 9, 2026 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Jan 15, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 8, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| Dec 10, 2025 | Citigroup | MAINTAIN | Neutral | Neutral |
| Dec 8, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Dec 5, 2025 | UBS | MAINTAIN | Neutral | Neutral |
| Dec 5, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Dec 5, 2025 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Dec 5, 2025 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Dec 5, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Dec 1, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Nov 26, 2025 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Oct 14, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Sep 17, 2025 | Roth MKM | UPGRADE | Neutral | Buy |
| Sep 12, 2025 | Guggenheim | REITERATE | Buy | Buy |
| Sep 11, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Aug 20, 2025 | Roth Capital | MAINTAIN | Neutral | Neutral |
| Aug 20, 2025 | JP Morgan | DOWNGRADE | Overweight | Neutral |
| Aug 12, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Jul 21, 2025 | Barclays | INITIATE | — | Equal-Weight |
| Jun 23, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Jun 23, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Jun 23, 2025 | UBS | MAINTAIN | Neutral | Neutral |
| Jun 23, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Jun 23, 2025 | Deutsche Bank | MAINTAIN | Hold | Hold |
| Jun 20, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Jun 17, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Jun 13, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| May 19, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| May 1, 2025 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Apr 3, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Mar 11, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 7, 2025 | Citigroup | MAINTAIN | Neutral | Neutral |
| Mar 7, 2025 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Mar 6, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Mar 3, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Feb 13, 2025 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Feb 7, 2025 | Guggenheim | MAINTAIN | Buy | Buy |
| Feb 6, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Jan 21, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Jan 6, 2025 | JP Morgan | MAINTAIN | Overweight | Overweight |
| Dec 23, 2024 | Telsey Advisory Group | MAINTAIN | Outperform | Outperform |
| Dec 20, 2024 | B of A Securities | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 9 | 10 | 14 | 0 | 0 | 58% | |
| May 1, 2026 | 9 | 10 | 14 | 0 | 0 | 58% | |
| Apr 1, 2026 | 9 | 10 | 14 | 0 | 0 | 58% | |
| Mar 1, 2026 | 9 | 10 | 14 | 0 | 0 | 58% | |
| Feb 1, 2026 | 9 | 11 | 13 | 0 | 0 | 61% | |
| Jan 1, 2026 | 9 | 10 | 13 | 0 | 0 | 59% |
Strong BuyBuyHoldSellStrong Sell
2 members of Congress traded this stock: 1 buys, 2 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | David Taylor | R | HOUSE | SELL | $1,001 - $15,000 | The Kroger Co | Apr 3, 2026 (11d) |
| Feb 26, 2026 | John Boozman | R | SENATE | BUY | $1,001 - $15,000 | The Kroger Co | Mar 6, 2026 (9d) |
| Feb 26, 2026 | David Taylor | R | HOUSE | SELL | $1,001 - $15,000 | The Kroger Co | Mar 9, 2026 (12d) |
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 27, 2026
short_volume
Short Volume: KR — 58.5% short (1.1M / 1.8M)
Short: 1,057,646 | Exempt: 652 | TRF Vol: 1,809,311 | Short Ratio: 58.5% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: KR — 68.6% short (2.4M / 3.5M)
Short: 2,411,389 | Exempt: 6,287 | TRF Vol: 3,515,514 | Short Ratio: 68.6% | Off-exchange volume (dark pool + OTC)
May 22, 2026
short_volume
Short Volume: KR — 62.1% short (1.2M / 2.0M)
Short: 1,222,705 | Exempt: 1,152 | TRF Vol: 1,967,886 | Short Ratio: 62.1% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: KR — 71.0% short (2.4M / 3.4M)
Short: 2,433,152 | Exempt: 531 | TRF Vol: 3,425,698 | Short Ratio: 71.0% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: KR — 69.1% short (1.2M / 1.8M)
Short: 1,217,995 | Exempt: 0 | TRF Vol: 1,762,009 | Short Ratio: 69.1% | Off-exchange volume (dark pool + OTC)
May 19, 2026
short_volume
Short Volume: KR — 60.6% short (1.7M / 2.7M)
Short: 1,658,134 | Exempt: 2,130 | TRF Vol: 2,736,163 | Short Ratio: 60.6% | Off-exchange volume (dark pool + OTC)
May 19, 2026
Enforcement
Solano v. the Kroger Co.
Court ruling from Court of Appeals for the Ninth Circuit. Docket: 25-536
May 18, 2026
short_volume
Short Volume: KR — 70.7% short (1.2M / 1.6M)
Short: 1,163,269 | Exempt: 3,470 | TRF Vol: 1,646,154 | Short Ratio: 70.7% | Off-exchange volume (dark pool + OTC)
May 11, 2026
short_volume
Short Volume: KR — 57.0% short (0.9M / 1.5M)
Short: 871,583 | Exempt: 524 | TRF Vol: 1,530,289 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
May 11, 2026
dark_pool
Dark Pool: KR — 5.3M shares, 103,767 trades
Week starting 2026-05-11. Total ATS volume: 5,261,725 shares across 103,767 trades.
May 8, 2026
short_volume
Short Volume: KR — 67.3% short (0.8M / 1.1M)
Short: 767,806 | Exempt: 1,033 | TRF Vol: 1,141,394 | Short Ratio: 67.3% | Off-exchange volume (dark pool + OTC)
May 6, 2026
short_volume
Short Volume: KR — 64.1% short (0.9M / 1.5M)
Short: 949,402 | Exempt: 450 | TRF Vol: 1,481,396 | Short Ratio: 64.1% | Off-exchange volume (dark pool + OTC)
May 5, 2026
short_volume
Short Volume: KR — 55.4% short (0.6M / 1.1M)
Short: 614,029 | Exempt: 468 | TRF Vol: 1,108,145 | Short Ratio: 55.4% | Off-exchange volume (dark pool + OTC)
May 4, 2026
short_volume
Short Volume: KR — 62.0% short (0.7M / 1.1M)
Short: 678,049 | Exempt: 233 | TRF Vol: 1,094,448 | Short Ratio: 62.0% | Off-exchange volume (dark pool + OTC)
May 4, 2026
dark_pool
Dark Pool: KR — 4.3M shares, 96,185 trades
Week starting 2026-05-04. Total ATS volume: 4,323,514 shares across 96,185 trades.
May 1, 2026
short_volume
Short Volume: KR — 55.4% short (0.7M / 1.3M)
Short: 709,060 | Exempt: 4,893 | TRF Vol: 1,279,009 | Short Ratio: 55.4% | Off-exchange volume (dark pool + OTC)
Apr 29, 2026
Enforcement
Chemical Toxin Working Grp. v. Kroger Co.
Court ruling from California Court of Appeal. Docket: B341662
Mar 2, 2026
Enforcement
Providence St. Joseph Health, et al., v. Actavis Holdco U.S., Inc., et al.; United Healthcare Services, Inc., v. Actavis Holdco U.S., Inc., et al.; 1199SEIU National Benefit Fund, et al., v. Actavis Holdco U.S., Inc.; CVS Pharmacy, Inc., v. Actavis Elizabeth, LLC, et al.; Rite Aid Corp., et al. v. Actavis Holdco U.S., Inc.; The Kroger Co., et al. v. Actavis Holdco U.S. Inc., et al.; J M Smith Corporation v. Actavis Holdco U.S. Inc., et al.; Walgreen Company, v. Actavis Holdco U.S. Inc., et al.; Humana Inc. v. Actavis Elizabeth, LLC, et al.; Molina Healthcare, Inc., v. Actavis Elizabeth, LLC, et al.; Health Care Service Corp. v. Actavis Elizabeth, LLC, et al.
Court ruling from District Court, E.D. Pennsylvania. Docket: 2:19-cv-05819
Mar 2, 2026
Enforcement
Providence St. Joseph Health, et al., v. Actavis Holdco U.S., Inc., et al.; United Healthcare Services, Inc., v. Actavis Holdco U.S., Inc., et al.; 1199SEIU National Benefit Fund, et al., v. Actavis Holdco U.S., Inc.; CVS Pharmacy, Inc., v. Actavis Elizabeth, LLC, et al.; Rite Aid Corp., et al. v. Actavis Holdco U.S., Inc.; The Kroger Co., et al v. Actavis Holdco U.S. Inc., et al.; J M Smith Corporation v. Actavis Holdco U.S. Inc., et al.; Walgreen Company, v. Actavis Holdco U.S. Inc., et al.; Humana Inc. v. Actavis Elizabeth, LLC, et al.; Molina Healthcare, Inc., v. Actavis Elizabeth, LLC et al.; Health Care Service Corp. v. Actavis Elizabeth, LLC et al.
Court ruling from District Court, E.D. Pennsylvania. Docket: 2:20-cv-00695